Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months (Q40366486)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 February 2010
edit
Language Label Description Also known as
English
Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months
scientific article published on 11 February 2010

    Statements

    Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months (English)
    Markus Knuf
    Fred Zepp
    Pirmin Habermehl
    Lothar Maurer
    Hanns-Michael Burow
    Ulrich Behre
    Michel Janssens
    Paul Willems
    Helmtrud Bisanz
    Volker Vetter
    Ruprecht Schmidt-Ott
    11 February 2010
    925-933

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit